Pronalis Tapfumaneyi | Toxicology and Pharmaceutical Science | Best Researcher Award

Datlabs Pvt Ltd|Zimbabwe

Pronalis Tapfumaneyi is a dedicated pharmacist and researcher with a strong background in public health and pharmaceutics. She’s currently pursuing her Master’s in Public Health at Africa University and has a Master’s degree in Pharmaceutics from Rhodes University, where she graduated with distinction. Pronalis has experience in regulatory affairs, clinical research, and community service, and is committed to improving healthcare outcomes.

Publication Profile

Orcid

Education

Master of Public Health (MPH): Pronalis is currently pursuing her MPH degree at Africa University, focusing on public health aspects that can significantly impact communities.Master of Science (MSc) in Pharmaceutics: She earned her MSc degree in Pharmaceutics from Rhodes University, where she graduated with distinction. Her research expertise in pharmaceutics has equipped her with a deep understanding of drug development and delivery systems. Bachelor of Pharmacy (BPharm): Pronalis completed her BPharm degree at Rhodes University, laying a solid foundation for her future academic and professional pursuits in pharmacy and public health. Her academic achievements demonstrate her commitment to excellence in her field, and her research experience has prepared her to tackle complex problems in public health and pharmaceutics.

Experience

Regulatory Affairs Pharmacist: Currently, Pronalis serves as a Regulatory Affairs Pharmacist at Datlabs (Pvt) Ltd, where she ensures compliance with regulatory requirements and oversees the development of new products. Regulatory Officer: Pronalis has also worked as a Regulatory Officer at the Medicines Control Authority of Zimbabwe, where she evaluated dossiers for regulatory compliance and issued registration certificates for medicines. Clinical Study Coordinator and Technician: At the Biopharmaceutics Research Institute, Pronalis coordinated clinical studies, managed study documents, and performed data analysis. Retail Pharmacist: Additionally, Pronalis has experience as a Retail Pharmacist at Medpoint Pharmacy, where she dispensed prescriptions, conducted health screenings, and advised patients on medication use. These experiences have equipped Pronalis with a broad understanding of the pharmaceutical industry, from research and development to regulatory affairs and patient care.

Honors and Awards

Dean’s Academic Merit List: Pronalis has been recognized for her outstanding academic performance, being included on the Dean’s Academic Merit List for her exceptional grades and scholarly contributions. Master of Science with distinction: She graduated with distinction in her Master of Science program, highlighting her academic excellence and research capabilities in her field. National Research Foundation (NRF) Innovation Scholarship: Pronalis was awarded a prestigious scholarship by the NRF to support her research endeavors, acknowledging her potential to make significant contributions to her field. Biopharmaceutics Research Institute Scholarship: She received a scholarship from the Biopharmaceutics Research Institute, further underscoring her research potential and academic achievements. Golden Key International Honor Society membership: Pronalis is a member of the Golden Key International Honor Society, an esteemed organization that recognizes academic excellence and leadership potential.

Research Focus

Public Health: Pronalis’s research in public health is geared towards understanding and addressing health challenges at the community level. This includes exploring strategies to enhance healthcare delivery, improve patient safety, and promote overall well-being. Pharmaceutics: Her work in pharmaceutics involves the study of drug formulation, delivery systems, and pharmacokinetics. Pronalis aims to develop effective and safe pharmaceutical products that meet the needs of diverse patient populations. Regulatory Affairs: Pronalis’s expertise in regulatory affairs ensures that pharmaceutical products and healthcare practices comply with relevant laws, regulations, and standards. This includes evaluating dossiers for regulatory compliance and ensuring that products meet safety and efficacy requirements. A significant aspect of her current research is her ongoing dissertation project, which investigates factors associated with reporting of adverse drug events among healthcare workers in Harare city polyclinics. Identify barriers and facilitators: Pronalis seeks to understand the factors that influence healthcare workers’ reporting of adverse drug events, including potential barriers and facilitators.

Publications

Solute–Vehicle–Skin Interactions and Their Contribution to Pharmacokinetics of Skin Delivery, which explores the delicate balance between molecular properties of drugs, skin properties, and formulation properties in percutaneous absorption.
Science of, and insights into, thermodynamic principles for dermal formulations, published in Drug Discovery Today.
The Pandemic and Your Skin – Direct and Indirect Impact of COVID-19, examining the effects of COVID-19 on skin health.
Fitting Pharmacodynamic Data to the Emax Model to Assess the Inherent Potency of Topical Corticosteroids, a study on assessing potency of topical corticosteroids.
Recent Advances and Future Prospective of Topical and Transdermal Delivery Systems, discussing advancements in topical and transdermal drug delivery systems.

Dr. Selim Sayın| Medicine | Best Researcher Award

Hematologist at Gülhane Educational and Research Hospital

Dr. Selim Sayın is a distinguished scholar and expert in [specific field, e.g., materials science, mechanical engineering], with extensive experience in [specific research areas, e.g., nanomaterials, renewable energy technologies]. He is recognized for his contributions to advancing both theoretical and applied knowledge in his field, focusing on the development of sustainable technologies and advanced materials for industrial applications. Dr. Sayın’s career is marked by his commitment to innovation and excellence in research.

Professional Profiles:

Strengths for the Award

Strengths for the Award:

Diverse Clinical Experience: Dr. Sayın has worked in a variety of medical settings, which has given him a broad perspective on patient care and medical procedures. His work in military, educational, and research hospitals showcases his adaptability and leadership in handling different challenges in hematology.
Specialization in Hematology and Bone Marrow Transplantation: His focus on one of the most specialized and high-impact areas of medicine, particularly bone marrow transplantation, sets him apart as an expert whose work directly affects patients suffering from life-threatening blood disorders. This specialization is critical to community health.
Involvement in Cutting-Edge Research: Dr. Sayın has participated in high-impact clinical trials such as the ARGX-113-1801 and ITHACA trials. These trials, which focus on immune thrombocytopenia and multiple myeloma, reflect his commitment to pushing the boundaries of hematological treatments and making advancements that could significantly benefit patient care.
Research Impact: His research on stem cell collection methods, graft-versus-host disease prophylaxis, and therapeutic apheresis contributes directly to improving clinical outcomes in hematology. His published works serve as valuable resources for clinicians and researchers alike, extending his influence beyond his immediate practice.

Areas for Improvement

Broader Collaborative Efforts: While Dr. Sayın has contributed significantly to clinical research, expanding his network of collaboration with other national and international institutions could further enhance the visibility and reach of his work. Cross-disciplinary research partnerships could open new doors for innovative solutions to complex hematological conditions.

Public Engagement and Advocacy: Given his expertise, Dr. Sayın could focus more on public engagement and awareness campaigns about the importance of bone marrow transplants and blood diseases. This could position him as a thought leader, not just in academic circles but also in patient advocacy and public health.

Diversification of Research Areas: While his current research is critical, exploring additional areas within hematology, such as personalized medicine or genetic therapies for blood disorders, could further elevate his profile as a researcher and widen the impact of his work.

Education:

Dr. Selim Sayın earned his PhD in [specific field, e.g., Mechanical Engineering, Materials Science] from [University Name], focusing on [specific area of research]. He holds a Master’s degree in [related field] from [University Name], where he specialized in [specific area of study]. His academic foundation was laid with a Bachelor’s degree in [specific field, e.g., Engineering, Physics] from [University Name], where he developed his expertise in [mention core skills, e.g., materials characterization, computational modeling].

Pofessional Experience:

Dr. Sayın is currently serving as [current position, e.g., Associate Professor, Senior Researcher] at [Institution Name], where he has been leading research in [specific field, e.g., advanced materials, nanotechnology]. His professional experience includes [number] years of research and teaching, along with contributions to various high-impact projects. His previous roles at [mention previous institutions or companies] involved collaborations with industry and academia, where he developed innovative solutions for [mention specific problems or sectors, e.g., renewable energy systems, mechanical design].

Skills:

Dr. Sayın’s skill set includes [mention specific skills, e.g., advanced materials characterization, finite element analysis, computational fluid dynamics]. He is proficient in [mention software or tools, e.g., MATLAB, ANSYS, COMSOL], and has strong expertise in [mention techniques, e.g., experimental design, data analysis, simulation techniques]. His leadership in project management and ability to guide multidisciplinary teams is complemented by his deep understanding of both academic research and industrial applications.

Publications :

Conclusion:

Dr. Selim Sayın is a highly qualified and dedicated hematologist whose work in bone marrow transplantation and clinical trials makes him an outstanding candidate for the Community Impact Award and the Best Researcher Award. His strengths lie in his specialized knowledge, clinical excellence, and research contributions to treatments that improve patient outcomes in hematology. By expanding his collaborative efforts and public advocacy, Dr. Sayın could further enhance his impact on both the scientific community and public health.